Q4 2024 · 13F-HR
DEERFIELD MANAGEMENT COMPANY, L.P.holdings as filed
Filed 2025-02-14 · accession 0001213900-25-014236
$5.28B
Reported value
106
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670703107 | NUVL | NUVALENT INC | $1.41B | 26.7% | 17,991,024 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $298.8M | 5.66% | 23,996,036 | Common | SOLE |
| 457985AM1 | IART 0.5 08/15/25 | INTEGRA LIFESCIENCES HLDGS C | $168.2M | 3.19% | 174,364,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $161.9M | 3.07% | 2,671,921 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $159.1M | 3.01% | 11,835,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $142.5M | 2.70% | 3,258,332 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $125.0M | 2.37% | 2,972,787 | Common | SOLE |
| 00437EAB8 | — | ACCOLADE INC | $124.5M | 2.36% | 132,598,000 | Common | SOLE |
| 946784105 | WAY | WAYSTAR HLDG CORP | $120.9M | 2.29% | 3,295,260 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $117.7M | 2.23% | 862,000 | Common | SOLE |
| 02043QAB3 | ALNY 1 09/15/27 | ALNYLAM PHARMACEUTICALS INC | $117.3M | 2.22% | 110,000,000 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $110.9M | 2.10% | 10,514,657 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $110.9M | 2.10% | 4,314,340 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $110.4M | 2.09% | 8,883,160 | Common | SOLE |
| 604749AB7 | MIRM 4 05/01/29 | MIRUM PHARMACEUTICALS INC | $106.6M | 2.02% | 70,000,000 | Common | SOLE |
| 00653Q102 | AHCO | ADAPTHEALTH CORP | $92.5M | 1.75% | 9,711,410 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $82.2M | 1.56% | 7,304,302 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $82.2M | 1.56% | 21,231,974 | Common | SOLE |
| 112463104 | BKD | BROOKDALE SR LIVING INC | $78.5M | 1.49% | 15,612,264 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $70.3M | 1.33% | 2,736,000 | Common | SOLE |
| 29082K105 | EMBC | EMBECTA CORP | $67.5M | 1.28% | 3,270,535 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $66.3M | 1.26% | 5,193,823 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $65.4M | 1.24% | 3,133,011 | Common | SOLE |
| 690732102 | ACH | OWENS & MINOR INC NEW | $64.2M | 1.22% | 4,911,979 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $61.2M | 1.16% | 8,144,442 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $56.1M | 1.06% | 1,923,100 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $55.5M | 1.05% | 2,078,509 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $50.5M | 0.96% | 1,551,718 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $49.8M | 0.94% | 151,644 | Common | SOLE |
| 02081GAB8 | ATEC 0.75 08/01/26 | ALPHATEC HLDGS INC | $46.7M | 0.88% | 49,500,000 | Common | SOLE |
| 207410101 | CNMD | CONMED CORP | $41.9M | 0.79% | 611,964 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $41.2M | 0.78% | 3,379,399 | Common | SOLE |
| 29332G102 | EHABUSD | ENHABIT INC | $39.1M | 0.74% | 5,010,972 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $38.8M | 0.73% | 1,411,000 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $38.7M | 0.73% | 2,017,464 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $38.1M | 0.72% | 600,515 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $34.2M | 0.65% | 145,191 | Common | SOLE |
| 516544AB9 | LNTH 2.625 12/15/27 | LANTHEUS HLDGS INC | $33.7M | 0.64% | 25,255,000 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $32.9M | 0.62% | 2,596,033 | Common | SOLE |
| 71944F106 | PHR | PHREESIA INC | $32.0M | 0.61% | 1,271,832 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $31.3M | 0.59% | 1,795,174 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $30.5M | 0.58% | 7,195,956 | Common | SOLE |
| M5425M103 | INMD | INMODE LTD | $26.4M | 0.50% | 1,578,708 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $24.4M | 0.46% | 7,964,000 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $24.4M | 0.46% | 851,593 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $23.9M | 0.45% | 593,000 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $23.5M | 0.44% | 6,710,429 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $23.0M | 0.44% | 500,000 | PUT | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $21.5M | 0.41% | 1,497,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $21.5M | 0.41% | 240,218 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $20.5M | 0.39% | 2,631,000 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $19.7M | 0.37% | 861,814 | Common | SOLE |
| 29415F104 | NVST | ENVISTA HOLDINGS CORPORATION | $19.6M | 0.37% | 1,018,415 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $18.4M | 0.35% | 225,000 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $15.6M | 0.30% | 2,315,000 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $15.4M | 0.29% | 3,255,514 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $14.1M | 0.27% | 156,012 | Common | SOLE |
| 16934W106 | CMRXEUR | CHIMERIX INC | $13.1M | 0.25% | 3,771,342 | Common | SOLE |
| 20603L102 | CON | CONCENTRA GROUP HOLDINGS PAR | $12.9M | 0.24% | 650,000 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $12.8M | 0.24% | 1,562,942 | Common | SOLE |
| 00437E102 | ACCDUSD | ACCOLADE INC | $11.9M | 0.23% | 3,475,000 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $10.5M | 0.20% | 1,019,700 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $10.5M | 0.20% | 450,000 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $10.4M | 0.20% | 1,534,763 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $10.3M | 0.19% | 435,653 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $10.2M | 0.19% | 448,145 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $10.1M | 0.19% | 373,407 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $9.4M | 0.18% | 2,938,754 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $5.9M | 0.11% | 3,555,871 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $5.4M | 0.10% | 2,155,000 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $5.3M | 0.10% | 1,000,000 | Common | SOLE |
| 38942Q202 | CALC | CALCIMEDICA INC | $4.6M | 0.09% | 1,300,000 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $3.9M | 0.07% | 1,882,654 | Common | SOLE |
| 82933R308 | — | SINGULAR GENOMICS SYSTEMS IN | $3.2M | 0.06% | 166,162 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $3.0M | 0.06% | 583,913 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $2.0M | 0.04% | 1,066,962 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $1.3M | 0.03% | 92,787 | Common | SOLE |
| 09090D301 | — | BIOMX INC | $1.3M | 0.02% | 1,787,610 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $1.2M | 0.02% | 534,737 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORP | $1.1M | 0.02% | 23,827 | Common | SOLE |
| 68236X100 | TOI | THE ONCOLOGY INSTITUTE INC | $1.0M | 0.02% | 3,360,052 | Common | SOLE |
| 74765K113 | QSIAW | QUANTUM SI INC | $416,666 | 0.01% | 333,333 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $232,652 | 0.00% | 917 | Common | SOLE |
| 370334104 | GIS | GENERAL MLS INC | $220,325 | 0.00% | 3,455 | Common | SOLE |
| 29336T100 | 0E41 | ENLINK MIDSTREAM LLC | $145,137 | 0.00% | 10,257 | Common | SOLE |
| 438333106 | HNST | HONEST CO INC | $139,785 | 0.00% | 20,171 | Common | SOLE |
| 29089Q105 | EBS | EMERGENT BIOSOLUTIONS INC | $134,394 | 0.00% | 14,058 | Common | SOLE |
| 422347104 | HTLD | HEARTLAND EXPRESS INC | $129,557 | 0.00% | 11,547 | Common | SOLE |
| 909214306 | UIS | UNISYS CORP | $98,919 | 0.00% | 15,627 | Common | SOLE |
| 124155110 | BFLYW | BUTTERFLY NETWORK INC | $93,207 | 0.00% | 733,333 | Common | SOLE |
| 91851C201 | EGY | VAALCO ENERGY INC | $91,320 | 0.00% | 20,897 | Common | SOLE |
| 410345102 | HN9 | HANESBRANDS INC | $86,439 | 0.00% | 10,619 | Common | SOLE |
| 37247D106 | GNW | GENWORTH FINL INC | $79,036 | 0.00% | 11,307 | Common | SOLE |
| 27923Q109 | ECVT | ECOVYST INC | $78,822 | 0.00% | 10,317 | Common | SOLE |
| 157085101 | CERS | CERUS CORP | $77,470 | 0.00% | 50,305 | Common | SOLE |
| 294628102 | HP5A | EQUITY COMWLTH | $76,567 | 0.00% | 43,258 | Common | SOLE |
| 00081T108 | ACCO | ACCO BRANDS CORP | $76,424 | 0.00% | 14,557 | Common | SOLE |
| 68554V108 | OSUR | ORASURE TECHNOLOGIES INC | $75,442 | 0.00% | 20,898 | Common | SOLE |
| 67018T105 | NUS | NU SKIN ENTERPRISES INC | $70,237 | 0.00% | 10,194 | Common | SOLE |
| 38246G108 | GDRX | GOODRX HLDGS INC | $55,754 | 0.00% | 11,990 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $53,642 | 0.00% | 20,166 | Common | SOLE |
| 05601U105 | BRCC | BRC INC | $47,642 | 0.00% | 15,029 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $38,333 | 0.00% | 166,666 | Common | SOLE |
| 25525P107 | DHC | DIVERSIFIED HEALTHCARE TR | $36,444 | 0.00% | 15,845 | Common | SOLE |
| 68236X118 | TOIIW | THE ONCOLOGY INSTITUTE INC | $6,500 | 0.00% | 1,250,000 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $3,567 | 0.00% | 166,666 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.